![]() |
市場調查報告書
商品編碼
1383424
2030 年機器人義肢市場預測:按技術、肢體、最終用戶和地區進行的全球分析Robotic Prosthetics Market Forecasts to 2030 - Global Analysis By Technology (Microprocessor-Controlled Prosthetics, Myoelectric Prostheses, Machine Learning and Other Technologies), By Extremity, End User and By Geography |
根據Stratistics MRC預測,2023年全球機器人義肢市場規模將達15億美元,預計2030年將達到31億美元,預測期內年複合成長率為10.8%。
機器人義肢,也稱為仿生義肢,是指醫療技術和動態工程領域,涉及設計、開發和實施配備義肢技術和先進感測器技術的義肢或義肢。這些機器人義肢旨在替換或增強缺失或無功能的身體部位(通常是手臂、手、腿、腳等)。
據截肢者聯盟稱,美國有超過 200 萬人失去肢體,其中大多數(54%)是由於糖尿病和周邊動脈疾病疾病造成的,45% 是由於外傷造成的。
全球截肢人口的增加是機器人義肢市場的關鍵促進因素。事故、醫療狀況和高齡化等因素導致截肢者數量增加。因此,對先進的義肢和矯正器具解決方案的需求不斷成長,以改善這些人的活動能力和生活品質。機器人義肢提供增強的功能、自然的運動和矯正器具的用戶體驗,使其成為一個有吸引力的選擇。這種不斷成長的需求將推動市場創新和投資,進一步擴大世界各地截肢者的覆蓋範圍和可及性。
由於這些先進醫療設備的成本高昂,保險範圍往往有限,使得許多人在經濟上無法獲得它們。此外,許多保險公司不承擔全部醫療費用,這給患者帶來了經濟負擔。此外,認證和合規要求等法規障礙可能導致製造延遲和成本增加,從而阻礙市場成長。
人工智慧、先進材料和感測器系統矯正器具最尖端科技正在推動更複雜、更實用的義肢的開發。這些創新提高了使用者的行動能力、反應能力和舒適度。此外,3D 列印和客製化可實現客製化解決方案,遠端醫療和遠端監控可改善患者照護。該技術還有可能提高成本效率並使這些設備更便宜。總體而言,持續的技術進步正在擴大可能性,提高截肢者的生活品質,並擴大機器人義肢市場的範圍。
在矯正器具地區,可得性有限,限制了先進義肢和矯正器具技術的取得。在基礎設施、醫療保健設施不足和經濟困難的地區,患者可能很難獲得或購買這些改善生活的設備。這種獲取機會的不平等導致截肢者的醫療結果差異,生活品質下降,阻礙了市場成長。
COVID-19 的爆發對市場產生了多方面的影響。供應鏈中斷和製造延誤給生產和分銷帶來了挑戰。然而,這場大流行凸顯了遠端監控和遠端醫療解決方案的重要性,推動了義肢矯正器具和患者照護的創新。儘管獲得醫療服務的機會有限,但對遠距復健和遠距調整等先進義肢和矯正器具義肢的需求卻激增。在疫情大流行後,人們可能會重新關注改善可近性、與遠端醫療的整合以及彈性供應鏈,以更好地為需要機器人義肢的患者提供服務。
從市場區隔來看,上半身義肢預計將佔據最大的市場佔有率。上半身義肢,例如機械臂和機械手,為上肢缺陷或肢體殘疾的人提供了顯著的功能改善。這些對於抓取、操作和日常生活等任務至關重要,並有助於不斷成長的需求。此外,上半身機器人義肢和矯正器具的進步使得控制系統變得更加複雜和直覺,使它們對截肢者越來越有吸引力,從而推動了細分市場的擴張。
在市場上,醫院和診所領域預計將顯著成長。醫院和診所是醫療干涉和患者照護的重要中心,使其成為採用和提供機器人義肢解決方案的天然中心。此外,隨著這項技術變得更加先進和易於使用,醫療專業人員擴大將機器人義肢涵蓋治療方案中。此外,醫院和診所正在提供專門的機器人義肢服務,以擴大使用範圍並改善患者的治療效果,從而推動市場的顯著成長。
北美預計將主導市場的主要原因包括先進的醫療基礎設施、高水準的醫療費用以及領先的矯正器具和義肢製造商和研究機構的強大實力。此外,相對較高的肢體缺陷盛行率和人口高齡化增加了對先進義肢解決方案的需求。此外,有利的報銷政策和積極引進創新醫療技術的做法進一步提高了北美在機器人領域的市場佔有率。
由於高齡化和義肢缺陷數量的增加推動了對先進義肢和矯正器具解決方案的需求,預計亞太地區將呈現最高的市場成長率。在中國、日本和韓國等國家,技術進步和醫療保健投資的增加正在推動創新。此外,政府的支持措施以及醫療保健提供者和科技公司之間的合作也進一步支持市場擴張。
According to Stratistics MRC, the Global Robotic Prosthetics Market is accounted for $1.5 billion in 2023 and is expected to reach $3.1 billion by 2030 growing at a CAGR of 10.8% during the forecast period. Robotic prosthetics, also known as bionic prosthetics, refer to the field of medical technology and biomechanical engineering that involves the design, development, and implementation of artificial limbs or prosthetic devices equipped with robotics and advanced sensor technologies. These robotic prosthetic limbs are designed to replace or augment missing or non-functional body parts, typically arms, hands, legs, or feet.
According to the Amputee Coalition, of the more than 2 million people living with a loss of limb in the U.S., majority (54%) were due to diseases like diabetes, peripheral arterial disease etc. and 45% were due to trauma.
The growing global amputee population is a significant driver of the robotic prosthetics market. Factors such as accidents, medical conditions, and an aging population contribute to an increasing number of amputees. As a result, there is a growing demand for advanced prosthetic solutions to improve the mobility and quality of life of these individuals. Robotic prosthetics offer enhanced functionality, natural movement, and an improved user experience, making them a compelling choice. This rising demand fuels innovation and investment in the market, further expanding its reach and accessibility to amputees worldwide.
The high costs associated with these advanced devices often result in limited insurance coverage, making them financially inaccessible for many individuals. Many insurance providers may not fully cover the expenses, placing financial burdens on patients. Additionally, regulatory hurdles, including certification and compliance requirements, can lead to delays and increased manufacturing costs, hindering market growth.
Cutting-edge technologies, such as artificial intelligence, advanced materials, and sensor systems, enable the development of more sophisticated and functional prosthetic devices. These innovations enhance mobility, responsiveness, and comfort for users. Additionally, 3D printing and customization enable tailored solutions, while telehealth and remote monitoring offer improved patient care. Technology also drives cost efficiencies, potentially making these devices more affordable. Overall, ongoing technological advancements are expanding the possibilities, improving the quality of life for amputees, and broadening the reach of the robotic prosthetics market.
The limited availability of robotic prosthetic devices in certain regions restricts access to advanced limb replacement technology. In regions with inadequate infrastructure, healthcare facilities, or economic challenges, patients may struggle to access or afford these life-enhancing devices. This inequality in access can result in disparities in healthcare outcomes and a reduced quality of life for amputees, which hinders the growth of the market.
The COVID-19 pandemic has had a multifaceted impact on the market. Supply chain disruptions and manufacturing delays led to challenges in production and distribution. However, the pandemic underscored the importance of remote monitoring and telehealth solutions, driving innovation in prosthetic control and patient care. While access to healthcare services faced restrictions, the demand for advanced prosthetic solutions, like tele-rehabilitation and remote adjustments, surged. Post-pandemic, the market is likely to see a renewed focus on enhancing accessibility, telehealth integration, and resilient supply chains to better serve patients in need of robotic prosthetics.
The upper-body prosthetics segment is expected to capture the largest market share in the market. Upper-body prosthetics, such as robotic arms and hands, offer significant functional improvements for individuals with upper-limb limb loss or limb disabilities. They are crucial for tasks like grasping, manipulation, and daily activities, contributing to a higher demand. Additionally, advancements in upper-body robotic prosthetics have led to more sophisticated and intuitive control systems, making them increasingly appealing for amputees, which is fostering segment expansion.
The hospitals and clinics segment in the market is positioned for substantial growth. Hospitals and clinics are key centers for medical interventions and patient care, making them natural hubs for the adoption and provision of robotic prosthetic solutions. Moreover, as the technology becomes more advanced and accessible, healthcare professionals are increasingly incorporating robotic prosthetics into their treatment protocols. Additionally, hospitals and clinics offer specialized robotic prosthetic services, expanding access and improving patient outcomes, thus driving significant market growth.
North America is anticipated to dominate the market primarily due to its advanced healthcare infrastructure, high levels of healthcare expenditure, and significant presence of leading prosthetics manufacturers and research institutions. Moreover, a relatively high prevalence of limb loss cases, coupled with a growing aging population, is driving the demand for advanced prosthetic solutions. Additionally, favorable reimbursement policies and a proactive approach towards adopting innovative healthcare technologies further contribute to North America's market share in the robotics sector.
The Asia Pacific region is expected to exhibit the highest growth rate in the market due to the region's rapidly aging population, coupled with an increasing incidence of limb loss, which is driving demand for advanced prosthetic solutions. Technological advancements and rising healthcare investments in countries like China, Japan, and South Korea are fostering innovation. Additionally, supportive government initiatives and collaborations between healthcare providers and technology firms are further propelling market expansion.
Some of the key players in Robotic Prosthetics Market include: Aethon, Asensus Surgical, Endolite India Ltd, Hansen Medical, Inc., HDT Global Inc, Intuitive Surgical, Inc., Mazor Robotics Ltd., Medrobotics Corporation, Open Bionics, Ossur Americas, Ottobock, Re Walk Robotics, Shadow Robot Company, Smith & Nephew, Stryker Corporation, SynTouch, Inc and ZOLL Medical Corporation.
In October 2022, Researchers at the University of Utah's Bionic Engineering Lab have developed the "Utah Bionic Leg," the most advanced bionic leg ever created. Now, the university has forged a new partnership with the worldwide leader in the prosthetics industry, Ottobock, to license the technology behind the Utah Bionic Leg and bring it to individuals with lower-limb amputations.
In February 2022, New York-based engineering startup Esper Bionics has developed a prosthetic arm with intuitive self-learning technology that can predict intended movement faster than similar prosthetics.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.